MEDICAL PRODUCT, PREFERABLY FOR USE DURING THE TREATMENT OF A BONE CAVITY, METHOD FOR PRODUCING THE MEDICAL PRODUCT, AND MEDICAL KIT

Abstract

A medical product, preferably for use in the treatment, more particularly in the filling up and/or closure, of a bone cavity, the product having structural elements connected to one another, the structural elements being dividable at least into two groups of structural elements, namely at least into a first group of structural elements and into a second group of structural elements, the structural elements of the first group having a lower hardness than the structural elements of the second group. Furthermore, a method for producing the medical product and a medical kit.

Claims

1.-23. (canceled)

24. A medical product for use in the filling up and/or closure of a bone cavity having structural elements connected to one another, characterized in that the structural elements are dividable into at least two groups of structural elements, namely at least into a first group of structural elements and into a second group of structural elements, the structural elements of the first group having a lower hardness than the structural elements of the second group.

25. The medical product of claim 24, characterized in that the product is an implant, preferably a bone substitute material.

26. The medical product of 24, characterized in that the structural elements of the first group are flexible or bendy, more particularly elastic.

27. The medical product of claim 24, characterized in that the structural elements of the first group have a lower bending strength than the structural elements of the second group.

28. The medical product of claim 24, characterized in that the structural elements of the second group are dimensionally stable or load-bearing.

29. The medical product of claim 24, characterized in that the structural elements of the first group are identical or dividable into two or more subgroups, the structural elements of each subgroup being identical to one another and the structural elements of different subgroups being different from one another.

30. The medical product of claim 24, characterized in that the structural elements of the second group are identical or dividable into two or more subgroups, the structural elements of each subgroup being identical to one another and the structural elements of different subgroups being different from one another.

31. The medical product of claim 24, characterized in that the structural elements of the first group are elongated structural elements, i.e., structural elements having a length-to-width ratio or length-to-diameter ratio greater than 1.

32. The medical product of claim 24, characterized in that the product has a planar structure, more particularly sheet-shaped planar structure, constructed from the structural elements of the first and second group, the length and width of which planar structure is in each case larger than the thickness or height of said planar structure.

33. The medical product of claim 24, characterized in that the structural elements of the first and/or second group have holes or openings.

34. The medical product of claim 24, characterized in that structural elements of the first group that are connected to one another form a number of intended bending regions of the product, more particularly of the planar structure.

35. The medical product of claim 34, characterized in that the intended bending regions surround in each case at least one, more particularly just one, structural element of the second group.

36. The medical product of claim 35, characterized in that the intended bending regions surround the at least one structural element of the second group in a cornerless manner, more particularly in the shape of a circular ring.

37. The medical product of claim 35, characterized in that the intended bending regions surround the at least one structural element of the second group in a polygonal manner, more particularly in the shape of a triangle, in the shape of a quadrangle, in the shape of a pentagon and/or in the shape of a hexagon.

38. The medical product of claim 34, characterized in that the intended bending regions are in each case in rows, more particularly in the form of rows arranged in parallel to one another.

39. The medical product of claim 34, characterized in that the intended bending regions are curved, arched or meandering, such as sinusoidal.

40. The medical product of claim 34, characterized in that the intended bending regions are folding regions of the product.

41. The medical product of claim 34, characterized in that the intended bending regions are connected to one another at least in part via one or more structural elements of the second group.

42. The medical product of claim 24, characterized in that the structural elements of the first and/or second group comprise a resorbable material or consist of such a material, the material preferably being selected from the group consisting of polyhydroxyalkanoate, protein, such as extracellular protein, polysaccharide, such as cellulose derivative or mucopolysaccharide, stereoisomers, more particularly diastereomers, thereof, salts thereof, copolymers thereof and combinations, more particularly composites, mixtures or blends, of at least two of the stated materials.

43. The medical product of claim 24, characterized in that the structural elements of the first and/or second group comprise a nonresorbable material or consist of such a material, the material preferably being selected from the group consisting of polymer, such as polyolefin, polyester or polyamide, metal, ceramic and combinations, more particularly composites, mixtures or blends, of at least two of the stated materials.

44. The medical product of claim 24, characterized in that the structural elements of the first and/or second group or a coating of the structural elements of the first and/or second group contain an additive, more particularly a medical and/or biological active ingredient, preferably selected from the group consisting of antimicrobial, more particularly antibiotic, active ingredient, wound healing-promoting active ingredient, disinfectant active ingredient, inflammation-inhibiting or anti-inflammatory active ingredient, blood coagulation-promoting active ingredient, growth factor, such as bone growth factor (osteoinductive factor), cell-differentiation factor, cell-adhesion factor, cell-recruitment factor, cell receptor, cell-binding factor, cytokine, peptide, structural protein, extracellular protein, such as collagen, elastin, reticulin and the like, serum protein, such as albumin, polysaccharide, such as hyaluronic acid, oligonucleotide, polynucleotide, DNA, RNA, salts thereof, stereoisomers, more particularly diastereomers, thereof and mixtures of at least two of the stated active ingredients.

45. A method for producing a medical product of claim 24, characterized in that the product is produced by means of a 3D-printing process.

46. A medical kit for use in the filling up and/or closure of a bone cavity, comprising a medical product as claimed in any of claims 1 to 21 and an attachment means, such as preferably a suture material or at least one bone screw.

Description

BRIEF DESCRIPTIONS OF THE FIGURES

[0128] In the figures, the following is shown schematically:

[0129] FIG. 1: shows one embodiment of a product according to the invention,

[0130] FIG. 2: shows a compressed, more particularly folded, state of the product depicted in FIG. 1,

[0131] FIG. 3: shows a more strongly compressed, more particularly folded, state of the product depicted in FIG. 1,

[0132] FIG. 4: shows a structural element of the first group,

[0133] FIG. 5: shows a further embodiment of a product according to the invention and

[0134] FIG. 6: shows a further embodiment of a product according to the invention.

DETAILED DESCRIPTION OF THE FIGURES

[0135] FIG. 1 shows schematically one embodiment of a medical product 100 according to the present invention.

[0136] The medical product 100 is preferably a bone substitute material or bone filler material.

[0137] The product 100 comprises a first group of structural elements 110 and a second group of structural elements 120. In this connection, the structural elements 110 have a lower hardness than the structural elements 120.

[0138] The different hardnesses of the structural elements 110 and 120 cause, in particular, different strengths of the structural elements 110 and 120. Preferably, the structural elements 110 are more elastic than the structural elements 120 and the structural elements 120 are more dimensionally stable than the structural elements 110.

[0139] The product 100 is present in the form of a planar structure. Preferably, the length L and the width B of the planar structure are each greater than the thickness of the planar structure. The planar structure can, in particular, be a sheet-shaped or carpet-type planar structure.

[0140] The structural elements 110 are in each case elongated, preferably web-shaped, and surround in each case a structural element 120. In this connection, the structural elements 110 connected to one another form intended bending regions, more particularly folding regions, of the product 100, along which the product 100 can be bent, more particularly folded. As a result, the product 100 can, with particular advantage, be matched with different bone-cavity openings and shapes. The intended bending regions, more particularly folding regions, can, as depicted in FIG. 1, be formed in a longitudinal direction, in a width direction (or transverse direction) and in a diagonal direction of the product 100.

[0141] The structural elements 120 have in each case the shape of a cylinder, more particularly flat cylinder, having triangular end faces.

[0142] The structural elements 110 can, for example, be formed from a resorbable material such as polylactide, poly-4-hydroxybutyrate or collagen, or from a nonresorbable material, such as, for example, an aliphatic polyurethane, for example from a polyurethane commercially available under the name Vasomer. The structural elements 120 can, for example, be formed from a nonresorbable material such as ultrahigh-molecular-weight polyethylene (UHMWPE), polymethyl methacrylate, nylon 6,6 or polyetherketone.

[0143] A bending, more particularly folding, of the medical product 100 along intended bending regions, more particularly folding regions, formed by the structural elements 110 is indicated in FIG. 2.

[0144] FIG. 3 shows schematically the product 100, as depicted in FIGS. 1 and 2, in a more strongly folded state. The product 100 can be transferred into such a state by bending, more particularly folding, along multiple intended bending regions, more particularly folding regions, formed by the structural elements.

[0145] FIG. 4 shows schematically a structural element 110 of the medical product 100 depicted in FIGS. 1 to 3. The structural element 110 is elongated, preferably web-shaped. For example, the structural element 110 can be in the form of a web having a quadrangular, more particularly rectangular, cross section. The structural element 110 has a length l, a width b and a thickness or height h.

[0146] FIG. 5 shows schematically a further embodiment of an inventive product 200 according to the present invention.

[0147] The medical product 200 is likewise preferably a bone substitute material or bone filler material.

[0148] Compared with the medical product 100 depicted in FIGS. 1 to 3, the product 200 depicted in FIG. 5 differs in that the structural elements of the first group can be divided into two subgroups, namely into a first subgroup of structural elements 210a and into a second subgroup of structural elements 210b. In this connection, the structural elements 210a and 210b differ in particular with respect to their shape. Whereas the structural elements 210a are in each case elongated, more particularly web-shaped, the structural elements 210b are in each case configured in the shape of a cylinder, more particularly flat cylinder, having circular end faces. Alternatively, the structural elements 210b can in each case be configured in the shape of a cylinder, more particularly flat cylinder, having polygonal, such as, for example, triangular, end faces (not depicted).

[0149] The structural elements 220 of the second group are in each case surrounded by three structural elements 210a and two structural elements 210b.

[0150] With regard to further features and advantages of the medical product 200 depicted in FIG. 5, reference is made to the preceding figure descriptions. The remarks made there with regard to the product 100 also apply mutatis mutandis to the product 200.

[0151] FIG. 6 shows schematically a further embodiment of an inventive product 300.

[0152] In the case of the product 300, the structural elements of the first group can be divided into two subgroups, namely into a first subgroup of structural elements 310a and into a second subgroup of structural elements 310b. In this connection, the structural elements 310a and 310b differ in particular with respect to their shape. Whereas the structural elements 310a are in each case elongated, more particularly web-shaped, the structural elements 310b are in each case configured in the shape of a cylinder, more particularly flat cylinder, having hexagonal end faces.

[0153] The structural elements 320 likewise have in each case the shape of a cylinder, more particularly flat cylinder, having hexagonal end faces.

[0154] The structural elements 320 are surrounded by the structural elements 310a and/or the structural elements 310b.

[0155] With regard to further features and advantages of the medical product 300 depicted in FIG. 6, reference is made to the remarks made in connection with FIGS. 1 to 4. The remarks made there with regard to the product 100 also apply mutatis mutandis to the product 300.

[0156] It is evident that the structural elements depicted in FIGS. 1 to 6 can also be formed from other materials. In this respect, reference is made in full to the materials stated in the general description.